NOVARTIS AG (NVSEF)
Clinical trial NCT07587723 updates: 1. start date: 2026-05-20 → 2026-06-23 2. completion date: 2026-08-20 → 2028-09-29 3. primary completion date: 2026-08-20 → 2028-09-29
Clinical trial NCT07587723 updates: 1. start date: 2026-05-20 → 2026-06-23 2. completion date: 2026-08-20 → 2028-09-29 3. primary completion date: 2026-08-20 → 2028-09-29
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical